Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Jazz Pharma

Jazz Pharmaceuticals

Rank: 49

Dublin, Ireland
www.jazzpharma.com

2020 Revenues ($USD) : $2,363,567,000
2020 R&D spend : $335,375,000
2020 Number of Employees : 1,940
Fiscal Year End : 12/31/2020
Key People : Bruce C. Cozadd, CEO

Jazz Pharma

Jazz Pharma facility in Dublin, Ireland



Jazz Pharmaceuticals is a global biopharmaceutical company developing medicines for people with serious diseases with limited or no options. Its treatments focus on neurosciences therapeutics and hematology and oncology. The Dublin, Ireland–based company has seven commercialized drugs. They include Xyrem and Xywav for treating cataplexy and EDS in adult and pediatric patients with narcolepsy; Sunosi for improving wakefulness in adult patients with EDS associated with narcolepsy or OSA; Defitelio for treating VOD; Erwinaze for patients who have developed hypersensitivity to E. coli-derived asparaginase while undergoing chemotherapy; Vyxeosfor treating adults with newly-diagnosed t-AML or AML-MRC and Zepzelca for treating adults with metastatic small lung cancer. Jazz Pharmaceuticals recently won FDA approval for its Vyxeos drug for treating secondary acute myeloid leukemia in pediatric patients. Company officials expect to acquire GW Pharmaceuticals for $7.2 billion, or $6.7 billion net of GW cash, later this year. –DK
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50